Status:

TERMINATED

Handwriting Interventions for People With Parkinson's

Lead Sponsor:

Oxford Brookes University

Collaborating Sponsors:

European Parkinson's Therapy Centre

Conditions:

Parkinson Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Background: Problems with handwriting are frustrating and debilitating and affect the majority of people with Parkinson's. Manifest as micrographia it is a distinctive feature of the condition charact...

Eligibility Criteria

Inclusion

  • Over 18 years old
  • Diagnosis of idiopathic Parkinson's disease
  • A score of ≤3 on the Hoehn and Yahr scale
  • Self-reported problem with handwriting (≥1 UPDRSII, 2.7)
  • Able to communicate in Italian
  • Following a stable medication regimen (no changes in the last 2 weeks and anticipated changes for the course of the study).

Exclusion

  • Severe depression or psychosis (history of),
  • reduced cognition that would preclude active involvement or capacity to consent (according to stages outlined in metal capacity act (ie trigger, information, existing diagnosis, functional test))
  • Orthopaedic, neurological or other condition that significantly impairs hand function,
  • Pregnancy

Key Trial Info

Start Date :

November 2 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 21 2022

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT03369587

Start Date

November 2 2017

End Date

April 21 2022

Last Update

July 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

European Parkinson's therapy centre

Darfo Boario Terme, Brescia, Italy, 25041